Item 15. Exhibit and Financial Statement Schedules

**(a)**The following documents are filed as part of this report:

(1) Financial Statements:


			Page(s)
Report of Independent Registered Public Accounting Firm — PricewaterhouseCoopers LLP			62
Consolidated Statement of Income for the three years ended December 31, 2024			64
Consolidated Statement of Comprehensive Income for the three years ended December 31, 2024			65
Consolidated Balance Sheet at December 31, 2024 and 2023			66
Consolidated Statement of Cash Flows for the three years ended December 31, 2024			67
Consolidated Statement of Equity for the three years ended December 31, 2024			68
Notes to the Consolidated Financial Statements			69 to 103

(2) Financial Statement Schedules:

Included below is Schedule II - Valuation and Qualifying Accounts for each of the three years in the period ended December 31, 2024.

(3) Exhibits:

The Exhibit Index on the following pages lists the exhibits that are filed as part of this report.

Schedule II — Valuation and Qualifying Accounts


	Year ended December 31
Millions of Dollars	2024		2023		2022
Employee Termination Benefits
Balance at January 1	$	6	$	11	$	43
Additions (reductions) charged to expense	987		(2)		1
Payments	(3)		(3)		(33)
Balance at December 31	$	990	$	6	$	11
Expected Credit Losses
Beginning allowance balance for expected credit losses	$	641	$	1,008	$	745
Current period provision	(30)		(367)		263

Write-offs charged against the allowance, if any	—		—		—

Balance at December 31	$	611	$	641	$	1,008
Deferred Income Tax Valuation Allowance*
Balance at January 1	$	20,416	$	19,532	$	17,651
Additions to deferred income tax expense	1,881		2,348		3,533
Reduction of deferred income tax expense	(984)		(1,464)		(1,652)
Balance at December 31	$	21,313	$	20,416	$	19,532